Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine

Hormone and Metabolic Research

Volumn 36, Issue 3, 2004, Pages 178-182

  Botella Carretero, J I ^a   Escobar Morreale, H F ^a   Martin I ^b   Valero, A M ^c   Alvarez, F ^a   Garcia C ^a   Varela, C ^a   Cantarero, M ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Gabinete Medico Velazquez   (Spain)

^c Unit of Pulmonology and Allergy   (Spain)

Author keywords

Insulin resistance; Lipid profile; Obesity

Indexed keywords

AMFEBUTAMONE; INSULIN; LIPID; NICOTINE;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING CESSATION; TREATMENT OUTCOME; WEIGHT GAIN;

ADMINISTRATION, CUTANEOUS; ADULT; AGING; BLOOD PRESSURE; BUPROPION; CARDIOVASCULAR DISEASES; DIASTOLE; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; OBESITY; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SMOKING CESSATION; THINNESS; WEIGHT GAIN;

EID: 1942472963     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814343     Document Type: Article

References (31)

1. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A, Rijcken B, Sawe U. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 1999; 13: 238-246
2. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-315
3. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-1202
4. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691
5. Holm KJ, Spencer CM. Bupropion: a review of its use in the management of smoking cessation. Drugs 2000; 59: 1007-1024
6. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995; 333: 1165-1170
7. O'Hara P, Connett JE, Lee WW, Nides M, Murray R, Wise R. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol 1998; 148: 821-830
8. Klesges RC, Ward KD, Ray JW, Cutter G, Jacobs DR Jr, Wagenknecht LE. The prospective relationships between smoking and weight in a young, biracial cohort: the Coronary Artery Risk Development in Young Adults Study. J Consult Clin Psychol 1998; 66: 987-993
9. Borrelli B, Spring B, Niaura R, Hitsman B, Papandonatos G. Influences of gender and weight gain on short-term relapse to smoking in a cessation trial. J Consult Clin Psychol 2001; 69: 511-515
10. Jeffery RW, Hennrikus DJ, Lando HA, Murray DM, Liu JW. Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychol 2000; 19: 242-246
11. Pomerleau CS, Zucker AN, Stewart AJ. Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers. Nicotine Tob Res 2001; 3: 51-60
12. Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S. Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health 1997; 51: 252-260
13. Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG. The effect of nicotine on energy expenditure during light physical activity. N Engl J Med 1989; 320: 898-903
14. Stamford BA, Matter S, Fell RD, Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. Am J Clin Nutr 1986; 43: 486-494
15. Hill AL, Roe DJ, Taren DL, Muramoto MM, Leischow SJ. Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Nicotine Tob Res 2000; 2: 247-253
16. Hughes JR, Hatsukami DK. Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight. J Subst Abuse 1997; 9: 151-159
17. Attvall S, Fowelin J, Lager I, von Schenck H, Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993; 233: 327-332
18. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-1130
19. Eliasson B, Taskinen MR, Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996; 94: 878-881
20. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997; 27: 450-456
21. Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M. Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 1999; 22: 357-360
22. Nilsson P, Lundgren H, Soderstrom M, Fagerstrom KO, Nilsson-E P. Effects of smoking cessation on insulin and cardiovascular risk factors - a controlled study of 4 months' duration. J Intern Med 1996; 240: 189-194
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
24. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991; 324: 739-745
25. Wee CC, Rjgotti NA, Davis RB, Phillips RS. Relationship between smoking and weight control efforts among adults in the united states. Arch Intern Med 2001; 161: 546-550
26. Jarry JL, Coambs RB, Polivy J, Herman CP. Weight gain after smoking cessation in women: the impact of dieting status. Int J Eat Disord 1998; 24: 53-64
27. Dale LC, Schroeder DR, Wolter TD, Croghan IT, Hurt RD, Offord KP. Weight change after smoking cessation using variable doses of transdermal nicotine replacement. J Gen Intern Med 1998; 13: 9-15
28. Sussman N, Ginsberg DL, Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor-and imipramine-controlled trials. J Clin Psyquiatry 2001; 62: 256-260
29. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298: 784-788
30. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 3619-3624
31. Lakka HM, Salonen JT, Tuomilehto J, Kaplan GA, Lakka TA. Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men. Horm Metab Res 2002; 34: 492-498